CVE:NSCI Nanalysis Scientific (NSCI) Stock Price, News & Analysis → Moonshot Coins for the Current Crypto Run (From Crypto 101 Media) (Ad) Free NSCI Stock Alerts C$0.45 -0.01 (-2.17%) (As of 11:23 AM ET) Add Compare Share Share Today's RangeC$0.45▼C$0.4650-Day RangeC$0.36▼C$0.4952-Week RangeC$0.35▼C$0.66Volume29,779 shsAverage Volume58,657 shsMarket CapitalizationC$50.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get Nanalysis Scientific alerts: Email Address Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. About Nanalysis Scientific Stock (CVE:NSCI)Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.Read More NSCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NSCI Stock News HeadlinesMay 29, 2024 | finance.yahoo.comNanalysis Announces First Quarter 2024 ResultsMay 29, 2024 | investing.comNanalysis Scientific Corp (NSCI)May 23, 2024 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp up on Tuesday (NSCI)May 21, 2024 | finance.yahoo.comNanalysis Announces First Quarter 2024 Conference CallMay 2, 2024 | finance.yahoo.comNanalysis Scientific Full Year 2023 Earnings: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022)April 30, 2024 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp up on Monday (NSCI)April 29, 2024 | ca.finance.yahoo.comNanalysis Announces Fourth Quarter and Full Year 2023 ResultsApril 27, 2024 | msn.comStudy supports gene-directed management of BRCA1 and BRCA2 gene carriers in SingaporeApril 27, 2024 | msn.comAnalysis identifies 50 new genomic regions associated with kidney cancer riskApril 11, 2024 | ca.finance.yahoo.comNanalysis Announces Full Year 2023 Conference CallApril 10, 2024 | ca.finance.yahoo.comNanalysis Scientific Corp. Announces Director ResignationApril 4, 2024 | theglobeandmail.comAI Revolutionizes Drug Detection with Compact NMR and Machine LearningMarch 31, 2024 | msn.comScientists identify distinct molecular signatures for sepsis diagnosis and prognosisMarch 6, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - NSCIMarch 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - NSCIFebruary 6, 2024 | finanznachrichten.deNanalysis Scientific Corp.: Nanalysis Achieves Record Revenue in Q4February 6, 2024 | msn.comNanalysis Scientific says Q4 revenue expected to be at least $9.3MFebruary 6, 2024 | finance.yahoo.comNanalysis Achieves Record Revenue in Q4January 30, 2024 | finance.yahoo.comNanalysis Scientific Corp. Provides Update on Security Services BusinessDecember 15, 2023 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp flat on Thursday (NSCI)December 2, 2023 | morningstar.comNanalysis Scientific Corp Ordinary Shares NSCIDecember 1, 2023 | finanznachrichten.deNanalysis Scientific Corp.: Nanalysis Reports Third Quarter 2023 ResultsNovember 29, 2023 | finance.yahoo.comNanalysis Reports Third Quarter 2023 ResultsNovember 15, 2023 | finance.yahoo.comNanalysis Announces Third Quarter 2023 Conference CallNovember 2, 2023 | finance.yahoo.comNanalysis Scientific Corp. (NSCIF)See More Headlines Receive NSCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolCVE:NSCI CUSIPN/A CIKN/A Webwww.nanalysis.com Phone403-769-9499FaxN/AEmployees249Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.16) Trailing P/E RatioN/A Forward P/E Ratio22.22 P/E GrowthN/ANet IncomeC$-16,200,000.00 Net Margins-56.90% Pretax MarginN/A Return on Equity-47.24% Return on Assets-13.67% Debt Debt-to-Equity Ratio93.56 Current Ratio1.23 Quick Ratio1.11 Sales & Book Value Annual SalesC$28.47 million Price / Sales1.82 Cash FlowC$0.05 per share Price / Cash Flow8.93 Book ValueC$0.23 per share Price / Book2.00Miscellaneous Outstanding Shares112,540,000Free FloatN/AMarket CapC$51.77 million OptionableNot Optionable Beta0.76 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Sean Krakiwsky M.Sc. (Age 54)Founder, CEO, President & Director Comp: $276.41kMr. Randall McRae C.A.CPA, Corporate Controller & CFOMr. Julien MullerChief Technology OfficerDr. Heather PhillipsVice President of OperationsMr. Matthew SelingerInvestor Relations ManagerDr. Susanne RiegelVice President of Marketing & Product ManagerMr. Nick MacKenzieVice President of SalesDr. Greg McFeetorsHead of ManufacturingMr. Sime BuricExecutive Vice President of ServicesRobert BorkowskyExecutive OfficerMore ExecutivesKey CompetitorsexactEarthTSE:XCTBSM TechnologiesTSE:GPSENTRECTSE:ENTEurocontrol Technics GroupCVE:EUOJEMTECCVE:JTCView All CompetitorsInsidersGuido CloetensSold 10,000 sharesTotal: C$4,700.00 ($0.47/share)Guido CloetensSold 10,000 sharesTotal: C$4,400.00 ($0.44/share)Michal OkoniewskiBought 80,000 shares on 3/18/2024Total: C$30,400.00 ($0.38/share)View All Insider Transactions NSCI Stock Analysis - Frequently Asked Questions How have NSCI shares performed in 2024? Nanalysis Scientific's stock was trading at C$0.38 at the beginning of the year. Since then, NSCI stock has increased by 20.0% and is now trading at C$0.45. View the best growth stocks for 2024 here. What other stocks do shareholders of Nanalysis Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nanalysis Scientific investors own include Brookfield Infrastructure Partners (BIP.UN), Big 5 Sporting Goods (BGFV), BlackBerry (BB), Ayro (AYRO), Digital Turbine (APPS), Alamos Gold (AGI) and Air Canada (AC). How do I buy shares of Nanalysis Scientific? Shares of NSCI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NSCI) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanalysis Scientific Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanalysis Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.